Mondrian Investment Partners LTD Supernus Pharmaceuticals, Inc. Transaction History

Mondrian Investment Partners LTD

  • $6.01 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 09, 2022
SELL
$25.33 - $34.25 $35,487 - $47,984
-1,401 Closed
0 $0
Q1 2022

May 05, 2022
SELL
$28.51 - $32.9 $3.96 Million - $4.57 Million
-138,933 Reduced 99.0%
1,401 $45,000
Q3 2021

Oct 27, 2021
BUY
$23.54 - $31.39 $1.11 Million - $1.48 Million
47,229 Added 50.73%
140,334 $3.74 Million
Q1 2021

May 10, 2021
BUY
$24.15 - $31.45 $2.25 Million - $2.93 Million
93,105 New
93,105 $2.84 Million

Others Institutions Holding SUPN

# of Institutions
282
Shares Held
60.9M
Call Options Held
27.7K
Put Options Held
11.3K
View Full List

About SUPERNUS PHARMACEUTICALS, INC.

SUPN Quotes by TradingView
  • Ticker SUPN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 53,495,300
  • Market Cap $1.9B
  • Description
  • Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States. Its commercial products are Trokendi XR, an extended release topiramate product indicated for the treatment of epilepsy, as well as for the prop...
More about SUPN
Track This Portfolio

Track Mondrian Investment Partners LTD Portfolio

Follow Mondrian Investment Partners LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mondrian Investment Partners LTD, based on Form 13F filings with the SEC.

News

Stay updated on Mondrian Investment Partners LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email